Evan B. Cunningham

Economic Recovery After the COVID-19 Pandemic: Resuming Elective Orthopedic Surgery and Total Joint Arthroplasty

Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies

Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission

Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes

A global view of hepatocellular carcinoma: trends, risk, prevention and management

Intimate partner violence and receptive syringe sharing among women who inject drugs in Indonesia: A respondent-driven sampling study

Direct-acting antiviral agents for HCV infection affecting people who inject drugs

Hepatitis C reinfection after sustained virological response

HCV epidemiology in high-risk groups and the risk of reinfection

Global burden of liver disease: 2023 update

Hepatitis C: global epidemiology and strategies for control

Adoption of Digital Technologies in Health Care During the COVID-19 Pandemic: Systematic Review of Early Scientific Literature

Global prevalence of hepatitis C virus in women of childbearing age in 2019: a modelling study

Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis

Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus

Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection

Resurgent Methamphetamine Use at Treatment Admission in the United States, 2008–2017

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Sexually Transmitted Infections Treatment Guidelines, 2021

The Effect of Intimate Partner Violence on the Physical Health and Health-Related Behaviors of Women: A Systematic Review of the Literature

Improvements in diagnosis of histoplasmosis

Cost‐effectiveness of scaling‐up HCV prevention and treatment in the United States for people who inject drugs

A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1

EASL Recommendations on Treatment of Hepatitis C 2018

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG

Drug and Opioid-Involved Overdose Deaths — United States, 2017–2018

Global Elimination of Chronic Hepatitis

Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment

Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection

Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America

Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review

Mixed HCV infection and reinfection in people who inject drugs—impact on therapy

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse

Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study

Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada

Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis

Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study

Variability in commercial histoplasma complement fixation antigens

Great Recession, great recovery? Trends from the Current Population Survey

Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs